TTK Healthcare, a company in the Diversified industry, reported revenue of ₹233 crore and net profit of ₹223 crore for the September 2026 quarter.
TTK Healthcare (NSE: TTKHLTCARE) closed at ₹1,110.15 on 20 Nov 2026, down 0.0% over the past year. Its market capitalisation is ₹1,569 crore and it trades at 21.6 times earnings.
TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. Human Pharma was divested in May 2022; agreements to sell EVA and Good Home were signed in July 2026.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.